Takeda Pharmaceutical Co. Newsletter
-
Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026?
31 Jan 2026 14:47 GMT
… stocks to buy for 2026. Takeda Pharmaceutical Company Limited (NYSE:TAK) reported … ’s 45.7% drop. Is Takeda Pharmaceutical Company Limited (TAK) One of … , renal dysfunction, and hypersensitivity remain. Takeda Pharmaceutical Company Limited (NYSE:TAK) is …
-
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2026 Earnings Call Transcript
30 Jan 2026 13:08 GMT
… Transcript January 29, 2026
Takeda Pharmaceutical Company Limited misses on … Session
Follow Takeda Pharmaceutical Co Ltd (NYSE:TAK) Follow Takeda Pharmaceutical Co Ltd … call.]
Follow Takeda Pharmaceutical Co Ltd (NYSE:TAK) Follow Takeda Pharmaceutical Co Ltd …
-
Hematopoietic Stem Cell Transplantation (HSCT) Market Booming with Rapid Growth Through 2033 | CellGenix GmbH
03 Feb 2026 10:18 GMT
…
◘ Kiadis Pharma
◘ Taiga Biotechnologies Inc.
◘ Takeda Pharmaceutical Company Limited
◘ Escape Therapeutics Inc …
-
FedEx Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks
02 Feb 2026 16:37 GMT
… , Inc.
A
B
A
TAK
Takeda Pharmaceutical Co. Ltd. Sponsored ADR
A …
-
Takeda Pharmaceutical Non-GAAP EPS of ¥279.00, revenue of ¥2219.5B; updates FY outlook
30 Oct 2025 09:25 GMT
Takeda Pharmaceutical press release (TAK): 1H Non- …
-
Innovent seals lucrative $11.4b deal with Takeda Pharmaceutical
22 Oct 2025 03:37 GMT
… announced a sweeping partnership with Takeda Pharmaceutical, with a total potential transaction …
-
Japan strengthening biopharma capabilities
31 Jan 2026 16:31 GMT
… company formed with investments from Takeda Pharmaceutical Company, Astellas Pharma Inc., and …
-
Takeda Pharmaceutical to exit cell therapy research
01 Oct 2025 14:46 GMT
-Japanese drugmaker Takeda Pharmaceutical said on Wednesday it will …
-
Takeda Pharmaceutical Company Limited (TAK) Advances γδ T Cell Cancer Treatments
28 Aug 2025 09:03 GMT
… placed tenth among them. Takeda Pharmaceutical Company Limited (NYSE:TAK), … its oncology portfolio. Additionally, Takeda Pharmaceutical Company Limited (NYSE:TAK) … in cancer and related diseases. Takeda Pharmaceutical Company Limited (TAK) Advances …
-
Takeda Flags Vyvanse Hit, Lifts 2025 Profit Guidance On Cost Control
29 Jan 2026 14:39 GMT
Takeda Pharmaceutical Company Limited (NYSE:TAK) posted … the list.
TAK Price Action: Takeda Pharmaceutical Co shares were up 0 …
About
© 1995-2026